ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype defined by a lack of expression of the estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor 2 (HER2) [1].